Evaluation of three different methods for susceptibility testing of gentamicin in carbapenem resistant

Yeliz Tanriverdi Cayci1, Kubra Hacieminoglu Ulker1, Asuman Birinci1

  • 1Department of Medical Microbiology, Faculty of Medicine, Ondokuz Mayıs University, Samsun, Turkey.

Le Infezioni in Medicina
|February 11, 2022
PubMed

Insights

Determining gentamicin susceptibility in carbapenem-resistant Enterobacterales (CRE) is crucial. The disk diffusion method demonstrated the highest accuracy compared to automated systems and broth microdilution, making it a reliable option.

Area of Science:

  • Clinical Microbiology
  • Antimicrobial Resistance
  • Infectious Diseases

Background:

  • Carbapenem-resistant Enterobacterales (CRE) pose a significant global health threat due to limited treatment options.
  • Gentamicin remains a key therapeutic agent for CRE infections, necessitating accurate susceptibility testing.
  • Previous studies suggest a need to evaluate automated systems for gentamicin susceptibility testing in CRE.

Purpose of the Study:

  • To compare the accuracy of three methods for determining gentamicin susceptibility in CRE isolates.
  • To assess the performance of automated systems (Vitek 2 Compact, Microscan Walkaway Plus) against the disk diffusion (DD) method and broth microdilution (BMD) as a reference.

Main Methods:

  • 107 CRE isolates were tested for gentamicin susceptibility using Vitek 2 Compact, Microscan Walkaway Plus, and DD methods.
  • Broth microdilution (BMD) served as the gold standard for comparison.
  • Categorical agreement, minor, major, and very major errors were analyzed. Aminoglycoside-modifying enzyme genes were investigated in discrepant results.

Main Results:

  • The disk diffusion (DD) method exhibited the highest categorical agreement (98.1%) with BMD.
  • Vitek 2 Compact showed the lowest agreement (90.6%), with a high very major error rate (7.5%).
  • Aminoglycoside-modifying enzyme genes (aac(6')Ib, aph(2″)Ia) were identified in 8 discrepant isolates.

Conclusions:

  • The disk diffusion (DD) method is a reliable and accurate approach for determining gentamicin susceptibility in CRE.
  • Automated systems demonstrated acceptable, though lower, agreement with BMD compared to DD.
  • Discrepancies with automated systems may be linked to the presence of specific aminoglycoside-modifying enzymes.